Centene stock rises 4.44% and outperforms competitors
Updated
Updated · MarketWatch · May 6
Centene stock rises 4.44% and outperforms competitors
5 articles · Updated · MarketWatch · May 6
The shares closed at $55.33 on Wednesday as the S&P 500 gained 1.46% and the Dow rose 1.24% in a broadly positive US market session.
Centene beat peers including HCA Healthcare, IQVIA Holdings and Labcorp, whose shares posted far smaller moves or a slight decline.
Despite the gain, Centene remains 13.75% below its 52-week high of $64.15 reached on 12 May, while trading volume of 8.0 million topped its 50-day average of 6.7 million.
Why do analysts predict Centene's stock will fall despite its record quarter and raised guidance?
Can Centene's profit recovery survive a government crackdown on its primary cost-control tactics?